search
attachments
weblink
advanced
Overview
Content Tools
Tasks
DATE : 2013-10-23
TPC Group has shut a production line at its butadiene plant in Texas, US. A Polymerupdate source in the US informed that the line was shut on October 18, 2013 owing to technical issues. Repairs on the line are underway and it could not be ascertained as to when the line will be restarted. Located at Port Neches, Texas, US, the plant has a butadiene production capacity of 900 million lb/year.
SOURCE : PolymerUpdate
TPC Group has shut a production line at its butadiene plant in Texas, US. A Polymerupdate source in the US informed that the line was shut on October 18, 2013 owing to technical issues. Repairs on the line are underway and it could not be ascertained as to when the line will be restarted. Located at Port Neches, Texas, US, the plant has a butadiene production capacity of 900 million lb/year.
SOURCE : PolymerUpdate
DATE : 2013-10-19
Idemitsu Kosan is in plans to shut its No.2 styrene monomer (SM) plant for maintenance turnaround.A Polymerupdate source in Taiwan informed that the plant is likely to be shut in September 2014.
It is expected to remain off-stream for around one month.Located in Chiba, Japan, the plant has a production capacity of 220,000 mt/year.
SOURCE PolymerUpdate
Idemitsu Kosan is in plans to shut its No.2 styrene monomer (SM) plant for maintenance turnaround.A Polymerupdate source in Taiwan informed that the plant is likely to be shut in September 2014.
It is expected to remain off-stream for around one month.Located in Chiba, Japan, the plant has a production capacity of 220,000 mt/year.
SOURCE PolymerUpdate
Dow Jones Newswires -IDSS2-
Le 17/10/2013 à 9:31
PARIS (Dow Jones)--Le conglomérat Bolloré (BOL.FR) a lancé jeudi l'introduction en Bourse de sa filiale de batteries électriques et de stockage d'énergie Blue Solutions, pour une capitalisation estimée entre 346 et 418 millions d'euros.
Le groupe de transport et de médias a indiqué qu'il placerait 10% du capital de Blue Solutions sur Euronext Paris, à un prix indicatif estimé entre 12 euros et 14,50 euros par action, ce qui lui permettra de lever entre 35 et 42 millions d'euros. Une option de surallocation permettra de porter à 11% la part du capital mise en Bourse.
Blue Solutions fabrique notamment les batteries utilisées par les voitures électriques en libre service du groupe Bolloré, comme l'Autolib' à Paris.
Les actions offertes pourront être souscrites à compter de jeudi, avant une fixation du prix de l'offre le 29 octobre et une première cotation le 30.
Après enregistrement du document de base en septembre, l'Autorité des marchés financiers a donné son visa à l'opération mercredi, a indiqué Bolloré.
"Je suis très heureux d'annoncer aujourd'hui le lancement de l'introduction en bourse de Blue Solutions qui constitue une étape très importante pour l'entreprise et pour sa technologie unique de stockage d'électricité", a commenté le PDG du groupe, Vincent Bolloré, cité dans un communiqué.
BNP Paribas, Crédit Agricole Corporate and Investment Bank, Deutsche Bank AG et HSBC France agissent en qualité de chefs de file et teneurs de livre associés.
-Thomas Varela, Dow Jones Newswires; +331 40 17 17 72; thomasvarela@wsj.com
(END) Dow Jones Newswires
Le 17/10/2013 à 9:31
PARIS (Dow Jones)--Le conglomérat Bolloré (BOL.FR) a lancé jeudi l'introduction en Bourse de sa filiale de batteries électriques et de stockage d'énergie Blue Solutions, pour une capitalisation estimée entre 346 et 418 millions d'euros.
Le groupe de transport et de médias a indiqué qu'il placerait 10% du capital de Blue Solutions sur Euronext Paris, à un prix indicatif estimé entre 12 euros et 14,50 euros par action, ce qui lui permettra de lever entre 35 et 42 millions d'euros. Une option de surallocation permettra de porter à 11% la part du capital mise en Bourse.
Blue Solutions fabrique notamment les batteries utilisées par les voitures électriques en libre service du groupe Bolloré, comme l'Autolib' à Paris.
Les actions offertes pourront être souscrites à compter de jeudi, avant une fixation du prix de l'offre le 29 octobre et une première cotation le 30.
Après enregistrement du document de base en septembre, l'Autorité des marchés financiers a donné son visa à l'opération mercredi, a indiqué Bolloré.
"Je suis très heureux d'annoncer aujourd'hui le lancement de l'introduction en bourse de Blue Solutions qui constitue une étape très importante pour l'entreprise et pour sa technologie unique de stockage d'électricité", a commenté le PDG du groupe, Vincent Bolloré, cité dans un communiqué.
BNP Paribas, Crédit Agricole Corporate and Investment Bank, Deutsche Bank AG et HSBC France agissent en qualité de chefs de file et teneurs de livre associés.
-Thomas Varela, Dow Jones Newswires; +331 40 17 17 72; thomasvarela@wsj.com
(END) Dow Jones Newswires
DATE : 2013-10-15
TVK has started construction of its planned 130,000 tonne/year butadiene (BD) installation, with the CEO of its parent company MOL and Hungarian prime minister Viktor Orban laying the foundation stone, the company said on Tuesday.
Following an import-substitution strategy, VK will find buyers for its BD output from tyre makers across Hungary, CEO Zsolt Hernadi said.
Basic engineering for the forint (Ft) 30bn ($138m, €101m) plant, at TVK’s production complex in Tiszaujvaros, northern Hungary, will be provided by a consortium of German process engineering firm Lurgi and Hungary's OTF Contracting, MOL said.
The initial stage of construction will involve the building of a C4/C5 separation unit, it added.
The first commercial production of the installation was expected by the first quarter of 2015, the company said.
MOL’s Austrian rival, oil, gas and petrochemical group OMV has also opted to move into the BD value chain, having announced plans to construct a €230m BD plant in Burghausen, southeast Germany, by mid-2015, with the aim of accounting for approximately 6% of European BD production.
SOURCE Icis News
TVK has started construction of its planned 130,000 tonne/year butadiene (BD) installation, with the CEO of its parent company MOL and Hungarian prime minister Viktor Orban laying the foundation stone, the company said on Tuesday.
Following an import-substitution strategy, VK will find buyers for its BD output from tyre makers across Hungary, CEO Zsolt Hernadi said.
Basic engineering for the forint (Ft) 30bn ($138m, €101m) plant, at TVK’s production complex in Tiszaujvaros, northern Hungary, will be provided by a consortium of German process engineering firm Lurgi and Hungary's OTF Contracting, MOL said.
The initial stage of construction will involve the building of a C4/C5 separation unit, it added.
The first commercial production of the installation was expected by the first quarter of 2015, the company said.
MOL’s Austrian rival, oil, gas and petrochemical group OMV has also opted to move into the BD value chain, having announced plans to construct a €230m BD plant in Burghausen, southeast Germany, by mid-2015, with the aim of accounting for approximately 6% of European BD production.
SOURCE Icis News
DATE : 2013-10-15
Ford Motor Co and the University of Michigan just announced they would open a new $88 million battery research and manufacturing lab that they hope will accelerate a much-needed breakthrough for the stalling electric auto non-boom (electric cars accounted for less than 1 per cent of US auto sales last year; hybrids 3 per cent, according to the AP). And batteries are getting the blame.
One of the first persons they should talk to is Chengdu Liang, a staff scientist at Oak Ridge National Laboratory in Tennessee who was born and raised in Hunan province and came to the US about 15 years ago as a graduate student at the University of Tennessee- Knoxville, did a year of post-grad at Oak Ridge and stayed on there, becoming a staff scientist in 2006.
Since then his research has focused on the development of sustainable energy technologies. "Electrical energy storage is a very important and exciting area," he told China Daily recently, mentioning that China Daily was his favourite newspaper through his college years in Hunan.
"A sustainable energy future lies in the harvesting of intermittent renewable energies to a stable supply of electricity," he explained, in other words, "When the sun is not shining and the wind is not blowing, the supply of energy is drawing from massive storage of electricity."
And that means batteries, big batteries. "Large scale storage of electricity needs advanced battery systems that are safe, low cost, and high energy-density," Liang said.
This past summer, Liang and his team announced a major breakthrough that could have major implications for the quest for an ideal battery for electric cars, not to mention homes and hand-helds.
The secret lies in sulfur, as in lithium-sulfur. The most widely accepted technology for batteries today is lithium-ion, which is practical for consumer electronics but not for anything much bigger. "Large-scale energy storage like vehicles or the electricity grid - if you want to store energy from a solar panel or from a wind turbine - we cannot store it in a lithium-ion battery," Liang said. "It's too expensive."
With today's electric cars, he said, "one third of the price goes to the battery. If you had a vehicle and the gas tank cost one-third of the price, you would not buy that vehicle". Same goes for a battery, he said, which is really just an energy "tank".
Liang and his team had a hunch that sulfur held the answer.
People had been working with using sulfur as an electrolyte for years, but always dissolved in a liquid that bridged the anode and cathode, or positive and negative terminals. Liang and his team reworked the entire structure of the battery, discovered some new compounds for the elctrodes, but the major innovation was to use sulfur in its solid form.
Putting it all together, they discovered what Liang calls "the magic" of what he believes "is going to be the future of the next generation of batteries".
"Our approach is a complete change from the current battery concept of two electrodes joined by a liquid electrolyte, which has been used over the last 150 to 200 years," Liang said in an Oak Ridge release.
Judged by weight and density, the lithium-sulfur technology outperforms today's conventional lithium-ion four to one.
Lithium-sulfur is also promising because the cost is so low. "It's almost free - sulfur is an industry waste," Liang said. "And the lithium itself is not expensive either."
"Not only does sulfur store much more energy," Liang said, "but a lithium-sulfur device could help recycle a waste product into a useful technology."
Another advantage of the technology is that it does away with the need for flammable liquid electrolytes, which have caused fires on airliners recently.
And if that is not enough, the all-solid sulfur-based battery offers a solution to another problem: self-discharge. As Liang explains, when you charge up a battery and put it on the shelf, after a certain amount of time, it goes dead. In conventional electric car batteries with liquid electrolytes, you charge up your battery, drive to the airport, park and go on vacation for a week or two and come back, "unfortunately, because of self-discharge, you have to call AA".
Liang said that so far his team has noticed no self-discharge from their design.
The new battery is still in the testing "demo" stage and a patent is pending. As for when lithium-sulfur power packs will be available to cars and cell phones, he said "we still need some improvements and engineering work … we are scientists. We are working on the very fundamental research. We solve the scientific problem then give the engineers a chance to play with that.
"What we work out is the scientific problem," he said, and "the science question has been answered".
Liang says that Oak Ridge National Laboratory is "a very nice place to work. I really like the scientific environment here, everything is open, we have collaborations all over the world, anyone can come here to do research."
The folks at Ford and Michigan might do well to take note.
SOURCE AsiaOne News
Ford Motor Co and the University of Michigan just announced they would open a new $88 million battery research and manufacturing lab that they hope will accelerate a much-needed breakthrough for the stalling electric auto non-boom (electric cars accounted for less than 1 per cent of US auto sales last year; hybrids 3 per cent, according to the AP). And batteries are getting the blame.
One of the first persons they should talk to is Chengdu Liang, a staff scientist at Oak Ridge National Laboratory in Tennessee who was born and raised in Hunan province and came to the US about 15 years ago as a graduate student at the University of Tennessee- Knoxville, did a year of post-grad at Oak Ridge and stayed on there, becoming a staff scientist in 2006.
Since then his research has focused on the development of sustainable energy technologies. "Electrical energy storage is a very important and exciting area," he told China Daily recently, mentioning that China Daily was his favourite newspaper through his college years in Hunan.
"A sustainable energy future lies in the harvesting of intermittent renewable energies to a stable supply of electricity," he explained, in other words, "When the sun is not shining and the wind is not blowing, the supply of energy is drawing from massive storage of electricity."
And that means batteries, big batteries. "Large scale storage of electricity needs advanced battery systems that are safe, low cost, and high energy-density," Liang said.
This past summer, Liang and his team announced a major breakthrough that could have major implications for the quest for an ideal battery for electric cars, not to mention homes and hand-helds.
The secret lies in sulfur, as in lithium-sulfur. The most widely accepted technology for batteries today is lithium-ion, which is practical for consumer electronics but not for anything much bigger. "Large-scale energy storage like vehicles or the electricity grid - if you want to store energy from a solar panel or from a wind turbine - we cannot store it in a lithium-ion battery," Liang said. "It's too expensive."
With today's electric cars, he said, "one third of the price goes to the battery. If you had a vehicle and the gas tank cost one-third of the price, you would not buy that vehicle". Same goes for a battery, he said, which is really just an energy "tank".
Liang and his team had a hunch that sulfur held the answer.
People had been working with using sulfur as an electrolyte for years, but always dissolved in a liquid that bridged the anode and cathode, or positive and negative terminals. Liang and his team reworked the entire structure of the battery, discovered some new compounds for the elctrodes, but the major innovation was to use sulfur in its solid form.
Putting it all together, they discovered what Liang calls "the magic" of what he believes "is going to be the future of the next generation of batteries".
"Our approach is a complete change from the current battery concept of two electrodes joined by a liquid electrolyte, which has been used over the last 150 to 200 years," Liang said in an Oak Ridge release.
Judged by weight and density, the lithium-sulfur technology outperforms today's conventional lithium-ion four to one.
Lithium-sulfur is also promising because the cost is so low. "It's almost free - sulfur is an industry waste," Liang said. "And the lithium itself is not expensive either."
"Not only does sulfur store much more energy," Liang said, "but a lithium-sulfur device could help recycle a waste product into a useful technology."
Another advantage of the technology is that it does away with the need for flammable liquid electrolytes, which have caused fires on airliners recently.
And if that is not enough, the all-solid sulfur-based battery offers a solution to another problem: self-discharge. As Liang explains, when you charge up a battery and put it on the shelf, after a certain amount of time, it goes dead. In conventional electric car batteries with liquid electrolytes, you charge up your battery, drive to the airport, park and go on vacation for a week or two and come back, "unfortunately, because of self-discharge, you have to call AA".
Liang said that so far his team has noticed no self-discharge from their design.
The new battery is still in the testing "demo" stage and a patent is pending. As for when lithium-sulfur power packs will be available to cars and cell phones, he said "we still need some improvements and engineering work … we are scientists. We are working on the very fundamental research. We solve the scientific problem then give the engineers a chance to play with that.
"What we work out is the scientific problem," he said, and "the science question has been answered".
Liang says that Oak Ridge National Laboratory is "a very nice place to work. I really like the scientific environment here, everything is open, we have collaborations all over the world, anyone can come here to do research."
The folks at Ford and Michigan might do well to take note.
SOURCE AsiaOne News
DATE : 2013-10-14
China’s Shandong Wanda Chemical is planning to start up its 150,000 tonne/year butadiene (BD) plant at Dongying in end-2013 or early next year, a company source said on Monday. The company has been commissioning the plant in Shandong province since September, the source said.
The plant uses butylene as feedstock to produce BD through dehydrogenation, the source said.
SOURCE : Icis News
China’s Shandong Wanda Chemical is planning to start up its 150,000 tonne/year butadiene (BD) plant at Dongying in end-2013 or early next year, a company source said on Monday. The company has been commissioning the plant in Shandong province since September, the source said.
The plant uses butylene as feedstock to produce BD through dehydrogenation, the source said.
SOURCE : Icis News
DATE : 2013-10-12
Taiyo Petrochemical is likely to shut its styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Japan informed that the plant is likely to be shut in September 2014. It is expected to remain off-stream for around one month.
Located in Ube, Japan, the plant has a production capacity of 370,000 mt/year.
SOURCE PolymerUpdate
Taiyo Petrochemical is likely to shut its styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Japan informed that the plant is likely to be shut in September 2014. It is expected to remain off-stream for around one month.
Located in Ube, Japan, the plant has a production capacity of 370,000 mt/year.
SOURCE PolymerUpdate
DATE : 2013-10-12
AstraZeneca today announced that it has entered into an agreement with Janssen Pharmaceuticals K. K. in Japan to co-promote abiraterone acetate, an innovative oral therapy for the treatment of patients with prostate cancer.
Currently the main treatment option available to patients in Japan is medical castration, however prostate cancer can still progress in many patients because androgens are produced in other tissues. Abiraterone acetate, a CYP17-inhibitor, inhibits the key enzyme which modulates the production of androgens, hormones which stimulate prostate cancer cells to grow, from all sources in the body. This helps lower the level of androgens available to the prostate cancer cells, which is the goal of treatment in prostate cancer.
Janssen Pharmaceuticals K.K. submitted a marketing approval application for abiraterone acetate to the Japanese Ministy o Healh, Labour ad Welfare, in July 2013 for the treatment of prostate cancer. The product was approved in the US by the Foo ad Drug Administraion in April 2011, and in the EU by theEuropea Commission in September 2011 for the treatment of patients with metastatic castration-resistant prostate cancer.
Marc Dunoyer, executive Vice President, Global Products and Portfolio Strategy at AstraZeneca said: Japan is one of the fastest growing pharmaceutical markets, where AstraZeneca has a proven track record of successfully developing and marketing innovative medicines. Abiraterone acetate is a great addition to our existing portfolio of leading cancer treatments, with real potential to address an important and growing patient need. This deal is a strong strategic fit for AstraZeneca, reinforcing both our focus on oncology as a core therapy area and Japan as one of our key growth drivers.
Abiraterone acetate is indicated in the US and the EU for the treatment of patients with metastatic castration-resistant prostate cancer in combination with prednisone (steroid) before and after treatment with docetaxel (chemotherapy). Abiraterone acetate has been approved in 83 countries.
SOURCE Mena Report
AstraZeneca today announced that it has entered into an agreement with Janssen Pharmaceuticals K. K. in Japan to co-promote abiraterone acetate, an innovative oral therapy for the treatment of patients with prostate cancer.
Currently the main treatment option available to patients in Japan is medical castration, however prostate cancer can still progress in many patients because androgens are produced in other tissues. Abiraterone acetate, a CYP17-inhibitor, inhibits the key enzyme which modulates the production of androgens, hormones which stimulate prostate cancer cells to grow, from all sources in the body. This helps lower the level of androgens available to the prostate cancer cells, which is the goal of treatment in prostate cancer.
Janssen Pharmaceuticals K.K. submitted a marketing approval application for abiraterone acetate to the Japanese Ministy o Healh, Labour ad Welfare, in July 2013 for the treatment of prostate cancer. The product was approved in the US by the Foo ad Drug Administraion in April 2011, and in the EU by theEuropea Commission in September 2011 for the treatment of patients with metastatic castration-resistant prostate cancer.
Marc Dunoyer, executive Vice President, Global Products and Portfolio Strategy at AstraZeneca said: Japan is one of the fastest growing pharmaceutical markets, where AstraZeneca has a proven track record of successfully developing and marketing innovative medicines. Abiraterone acetate is a great addition to our existing portfolio of leading cancer treatments, with real potential to address an important and growing patient need. This deal is a strong strategic fit for AstraZeneca, reinforcing both our focus on oncology as a core therapy area and Japan as one of our key growth drivers.
Abiraterone acetate is indicated in the US and the EU for the treatment of patients with metastatic castration-resistant prostate cancer in combination with prednisone (steroid) before and after treatment with docetaxel (chemotherapy). Abiraterone acetate has been approved in 83 countries.
SOURCE Mena Report
DATE : 2013-10-11
According to news reporting originating in Shizuoka, Japan, by VerticalNews journalists, research stated, "Sulfide solid electrolytes, which show high ion conductivity, are anticipated for use as electrolyte materials for all-solid-state batteries. One drawback of sulfide solid electrolytes is their low chemical stability in air."
The news reporters obtained a quote from the research from Toyota, "They are hydrolyzed by moisture and generate H2S gas. Substituting oxygen atoms for sulfur atoms in sulfide solid electrolytes is effective for suppression of H2S gas generation in air. Especially, the xLi(2)O center dot(75-x)Li2S center dot 25P(2)S(5) (mol%) glasses hardly generated H2S gas in air. However, substituting oxygen atoms for sulfur atoms caused a decrease in conductivity. The x = 7 glass showed high chemical stability in air and maintained high conductivity of 2.5 x 10(-4) S cm(-1) at room temperature. Performance of cells using the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) and the 75Li(2)S center dot 25P(2)S(5) glasses as solid electrolytes were compared. All-solid-state C/LiCoO2 cell using the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) glass produced performance as good as that obtained using the 75Li(2)S center dot 25P(2)S(5) glass."
According to the news reporters, the research concluded: "Capacity retention and change of interfacial resistance of the former cell were superior to those of the latter cell after storage at 4.0 V and 60 A degrees C. The diffusion of oxygen element into the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) glass was less than that into the 75Li(2)S center dot 25P(2)S(5) glass after storage at the voltage of 4.0 V at 60 A degrees C. Improvement of the stability of sulfide solid electrolytes to moisture was related to cell performance as well as an increase in conductivity."
For more information on this research see: All-solid-state batteries with Li2O-Li2S-P2S5 glass electrolytes synthesized by two-step mechanical milling. Journal of Solid State Electrochemistry, 2013;17(10):2551-2557. Our news correspondents report that additional information may be obtained by contacting T. Ohtomo, Toyota MotorCo Ltd, Battery Res Div, Higashifuji Technical Center, Shizuoka 4101193, Japan.
SOURCE : Chemicals & Chemistry
According to news reporting originating in Shizuoka, Japan, by VerticalNews journalists, research stated, "Sulfide solid electrolytes, which show high ion conductivity, are anticipated for use as electrolyte materials for all-solid-state batteries. One drawback of sulfide solid electrolytes is their low chemical stability in air."
The news reporters obtained a quote from the research from Toyota, "They are hydrolyzed by moisture and generate H2S gas. Substituting oxygen atoms for sulfur atoms in sulfide solid electrolytes is effective for suppression of H2S gas generation in air. Especially, the xLi(2)O center dot(75-x)Li2S center dot 25P(2)S(5) (mol%) glasses hardly generated H2S gas in air. However, substituting oxygen atoms for sulfur atoms caused a decrease in conductivity. The x = 7 glass showed high chemical stability in air and maintained high conductivity of 2.5 x 10(-4) S cm(-1) at room temperature. Performance of cells using the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) and the 75Li(2)S center dot 25P(2)S(5) glasses as solid electrolytes were compared. All-solid-state C/LiCoO2 cell using the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) glass produced performance as good as that obtained using the 75Li(2)S center dot 25P(2)S(5) glass."
According to the news reporters, the research concluded: "Capacity retention and change of interfacial resistance of the former cell were superior to those of the latter cell after storage at 4.0 V and 60 A degrees C. The diffusion of oxygen element into the 7Li(2)O center dot 68Li(2)S center dot 25P(2)S(5) glass was less than that into the 75Li(2)S center dot 25P(2)S(5) glass after storage at the voltage of 4.0 V at 60 A degrees C. Improvement of the stability of sulfide solid electrolytes to moisture was related to cell performance as well as an increase in conductivity."
For more information on this research see: All-solid-state batteries with Li2O-Li2S-P2S5 glass electrolytes synthesized by two-step mechanical milling. Journal of Solid State Electrochemistry, 2013;17(10):2551-2557. Our news correspondents report that additional information may be obtained by contacting T. Ohtomo, Toyota MotorCo Ltd, Battery Res Div, Higashifuji Technical Center, Shizuoka 4101193, Japan.
SOURCE : Chemicals & Chemistry
DATE : 2013-10-10
While an acrylate esters consumer said late on Wednesday that its butyl acrylate (butyl-A) demand is fully covered for October, it remains to be seen what impact the force majeure at Arkema will have on the European market.
The consumer said: “We had a lot of carryover from September, which was relatively slow.”
French specialty chemicals company Arkema declared force majeure o Acrylic Acid (AA) and Butyl-A from its Carling site on 7 October, because of a “substantial mechanical failure”.
“I can confirm that we are in force majeure on butyl-A and AA, and we are managing our way through that at the moment,” a source from the company on Wednesday.
As a number of players are returning from the 47th annual European Petrochemical Association (EPCA) meeting in Berlin from 5-9 October, and as the declaration has only been announced this week, it is too early for sources to provide immediate feedback on the news.
In a company letter to its customers seen by ICIS, Arkema said the declaration will remain in place “for an undetermined period”.
The mechanical failure is understood to have occurred during the restart process of its production unit after a planned maintenance shutdown, the letter said.
Arkema has the capacity to produce 276,000 tonnes/year of crude AA at its Carling, France, site.
SOURCE Icis News
While an acrylate esters consumer said late on Wednesday that its butyl acrylate (butyl-A) demand is fully covered for October, it remains to be seen what impact the force majeure at Arkema will have on the European market.
The consumer said: “We had a lot of carryover from September, which was relatively slow.”
French specialty chemicals company Arkema declared force majeure o Acrylic Acid (AA) and Butyl-A from its Carling site on 7 October, because of a “substantial mechanical failure”.
“I can confirm that we are in force majeure on butyl-A and AA, and we are managing our way through that at the moment,” a source from the company on Wednesday.
As a number of players are returning from the 47th annual European Petrochemical Association (EPCA) meeting in Berlin from 5-9 October, and as the declaration has only been announced this week, it is too early for sources to provide immediate feedback on the news.
In a company letter to its customers seen by ICIS, Arkema said the declaration will remain in place “for an undetermined period”.
The mechanical failure is understood to have occurred during the restart process of its production unit after a planned maintenance shutdown, the letter said.
Arkema has the capacity to produce 276,000 tonnes/year of crude AA at its Carling, France, site.
SOURCE Icis News
DATE : 2013-10-09
French specialty chemicals producer Arkema has declared force majeure on Acrylic Acid (AA) and Butyl Acrylate (butyl-A) from its Carling, France site, because of a substantial mechanical failure, according to a company letter to its customers seen by ICIS on Wednesday.
SOURCE Icis News
French specialty chemicals producer Arkema has declared force majeure on Acrylic Acid (AA) and Butyl Acrylate (butyl-A) from its Carling, France site, because of a substantial mechanical failure, according to a company letter to its customers seen by ICIS on Wednesday.
SOURCE Icis News
DATE : 2013-10-08
China Petrochemical Development Corp (CPDC) is in plans to shut an Acrylonitrile (ACN) plant for maintenance turnaround. A Polymerupdate source in Taiwan informed that the plant is likely to be shut on October 26, 2013. It is expected to remain off-stream for around 15 days.Located in Tashe, Taiwan, the plant has a production capacity of 240,000 mt/year.
SOURCE PolymerUpdate
China Petrochemical Development Corp (CPDC) is in plans to shut an Acrylonitrile (ACN) plant for maintenance turnaround. A Polymerupdate source in Taiwan informed that the plant is likely to be shut on October 26, 2013. It is expected to remain off-stream for around 15 days.Located in Tashe, Taiwan, the plant has a production capacity of 240,000 mt/year.
SOURCE PolymerUpdate
DATE: 2013-10-08
Pars Petrochemical is in plans to shut a Styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Iran informed that the plant is likely to be shut in mid-October 2013. It is expected to remain off-stream for around one month.Located in Assaluyeh, Iran, the plant has a production capacity of 600,000 mt/year.
SOURCE PolymerUpdate
Pars Petrochemical is in plans to shut a Styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Iran informed that the plant is likely to be shut in mid-October 2013. It is expected to remain off-stream for around one month.Located in Assaluyeh, Iran, the plant has a production capacity of 600,000 mt/year.
SOURCE PolymerUpdate
DATE : 2013-10-09
Qixiang Tengda Chemical has been running its two Butadiene (BD) units in Shandong province at 25% of capacity since mid-May because of poor market conditions, a company source said on Wednesday.
The two BD units have a combined capacity of 150,000 tonnes/year, the source said.
"The cost of our production is too high. We just produce about 100 tonnes/day," the source said.
Qixiang Tengda Chemical produces BD through a butylene-hydrogenation process. Commercial production at the smaller BD unit started in May this year, while the bigger plant started operation in the same month in 2012, the source said.
"We just run at low rates and wait for [BD] prices to increase," the company source said.
SOURCE Icis News
Qixiang Tengda Chemical has been running its two Butadiene (BD) units in Shandong province at 25% of capacity since mid-May because of poor market conditions, a company source said on Wednesday.
The two BD units have a combined capacity of 150,000 tonnes/year, the source said.
"The cost of our production is too high. We just produce about 100 tonnes/day," the source said.
Qixiang Tengda Chemical produces BD through a butylene-hydrogenation process. Commercial production at the smaller BD unit started in May this year, while the bigger plant started operation in the same month in 2012, the source said.
"We just run at low rates and wait for [BD] prices to increase," the company source said.
SOURCE Icis News
DAE : 2013-10-07
FMC announced made a major announcement today that will expand its reach in the biological crop protection market through two key transactions.
FMC has signed a global collaboration agreement with Chr. Hansen, a biosciences company specializing in cultures, enzymes and fermentation, to develop and commercialize biological crop protection products. FMC also announced the acquisition of the Center for Agricultural and Environmental Biosolutions (CAEB), a division of North Carolina-based RTI International, which specializes in sustainable agriculture research.
FMC is poised to become a leader in biological crop protection,” said Mark Douglas, president, FMC Agricultural Solutions. “We now have a world-class library of microorganisms, deep expertise in biological discovery, and an exclusive strategic alliance with one of the world’s foremost authorities on microbial research and fermentation. We have a powerful platform from which we can launch a range of new products.”
While FMC has been known for its insecticides and herbicides, the company recently added several patented fungicides to its business. Now the company is building on its synthetic chemistries to offer a range of biological insecticides, herbicides and fungicides.
Alliance with Chr. Hansen
The new alliance with Chr. Hansen will allow FMC to compete in the multi-billion dollar biological crop protection market .Chr. Hansen will provide scouting, screening, scale up and fermentation manufacturing expertise while FMC will provide scouting, screening, formulation capabilities, product development and registration experience, and global market access.
FMC and Chr. Hansen have already worked on several projects together. The existing collaboration between the two companies will yield the Brazilian launch of the Nemix C product for use in sugarcane in late 2013, targeting the biggest sugarcane market in the world of 9 million hectares.
Acquisition of CAEB
FMC’s acquisition of CAEB gives the company a proprietary development platform through the addition of a state-of-the art research facility, a team of accomplished scientists, a pipeline of biological products in various stages of development and a world-class library of microbes with deep intellectual property assets, including patent-pending technologies.
CAEB’s facility, located in Research Triangle Park, N.C., will become a biological center within FMC’s global research and development network. The work conducted at the facility will feed into FMC’s alliance with Chr. Hansen.
SOURCE Farma Industry News
FMC announced made a major announcement today that will expand its reach in the biological crop protection market through two key transactions.
FMC has signed a global collaboration agreement with Chr. Hansen, a biosciences company specializing in cultures, enzymes and fermentation, to develop and commercialize biological crop protection products. FMC also announced the acquisition of the Center for Agricultural and Environmental Biosolutions (CAEB), a division of North Carolina-based RTI International, which specializes in sustainable agriculture research.
FMC is poised to become a leader in biological crop protection,” said Mark Douglas, president, FMC Agricultural Solutions. “We now have a world-class library of microorganisms, deep expertise in biological discovery, and an exclusive strategic alliance with one of the world’s foremost authorities on microbial research and fermentation. We have a powerful platform from which we can launch a range of new products.”
While FMC has been known for its insecticides and herbicides, the company recently added several patented fungicides to its business. Now the company is building on its synthetic chemistries to offer a range of biological insecticides, herbicides and fungicides.
Alliance with Chr. Hansen
The new alliance with Chr. Hansen will allow FMC to compete in the multi-billion dollar biological crop protection market .Chr. Hansen will provide scouting, screening, scale up and fermentation manufacturing expertise while FMC will provide scouting, screening, formulation capabilities, product development and registration experience, and global market access.
FMC and Chr. Hansen have already worked on several projects together. The existing collaboration between the two companies will yield the Brazilian launch of the Nemix C product for use in sugarcane in late 2013, targeting the biggest sugarcane market in the world of 9 million hectares.
Acquisition of CAEB
FMC’s acquisition of CAEB gives the company a proprietary development platform through the addition of a state-of-the art research facility, a team of accomplished scientists, a pipeline of biological products in various stages of development and a world-class library of microbes with deep intellectual property assets, including patent-pending technologies.
CAEB’s facility, located in Research Triangle Park, N.C., will become a biological center within FMC’s global research and development network. The work conducted at the facility will feed into FMC’s alliance with Chr. Hansen.
SOURCE Farma Industry News